{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:33:17Z","timestamp":1789075997288,"version":"build-2803163510"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Drug-induced liver injury (DILI) remains a major obstacle in clinical pharmacotherapy and a leading cause of acute liver failure and drug withdrawal worldwide. Conventional mechanistic models centered on hepatic xenobiotic metabolism, oxidative stress, and immune injury cannot fully account for the substantial interindividual variability and the unpredictable nature of idiosyncratic DILI. Increasing evidence shows that the gut microbiota and its metabolites critically shape hepatic susceptibility through modulation of drug metabolism, inflammatory signaling, and intestinal barrier integrity. This review summarizes current understanding of the gut\u2013liver axis in DILI pathogenesis, with a focus on microbial enzymes such as \u03b2-glucuronidase that reactivate detoxified drug conjugates, microbial dysbiosis that disrupts bile acid homeostasis, and depletion of short chain fatty acids and indole derivatives that normally support epithelial defenses and immunologic tolerance. Drug-specific microbial patterns are discussed, including acetaminophen, amoxicillin\u2013clavulanate, anti-tuberculosis regimens, and immune checkpoint inhibitors. We introduce the concept of metabotype-dependent hepatotoxicity, which emphasizes that individual microbial metabolic profiles influence DILI risk. Advances in metagenomics, metabolomics, and integrative multi-omics enable the identification of microbial biomarkers and functional pathways associated with DILI susceptibility. Emerging therapeutic strategies include restoration of microbial homeostasis, selective inhibition of microbial enzymes, and supplementation of hepatoprotective metabolites. Finally, we outline key challenges and future directions toward translating microbiome-based insights into clinical prediction and precision prevention of DILI. Importantly, this review integrates microbial metabolic functions with precision hepatology concepts, highlighting how metabotype-driven variability can be leveraged for individualized DILI risk assessment.<\/jats:p>","DOI":"10.3389\/fcimb.2025.1737234","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:29:53Z","timestamp":1765780193000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Gut microbiota-metabolite interactions in drug-induced liver injury: mechanisms, biomarkers, and therapeutic perspectives"],"prefix":"10.3389","volume":"15","author":[{"given":"Xiaoya","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"111921","DOI":"10.1016\/j.ejmech.2019.111921","article-title":"Therapeutic significance of \u03b2-glucuronidase activity and its inhibitors: A review","volume":"187","author":"Awolade","year":"2019","journal-title":"Eur. J. med Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/microorganisms3040641","article-title":"The gut microbiota as a therapeutic target in IBD and metabolic disease: a role for the bile acid receptors FXR and TGR5","volume":"3","author":"Baars","year":"2015","journal-title":"Microorganisms"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1085621","article-title":"Investigating bile acid-mediated cholestatic drug-induced liver injury using a mechanistic model of multidrug resistance protein 3 (MDR3) inhibition","volume":"13","author":"Beaudoin","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/d5030627","article-title":"Untangling the genetic basis of fibrolytic specialization by Lachnospiraceae and Ruminococcaceae in diverse gut communities","volume":"5","author":"Biddle","year":"2013","journal-title":"Diversity"},{"key":"B6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejim.2021.10.035","article-title":"Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management","volume":"97","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Eur. J. Internal Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cld.2018.01.007","article-title":"Acetaminophen (APAP or N-acetyl-p-aminophenol) and acute liver failure","volume":"22","author":"Bunchorntavakul","year":"2018","journal-title":"Clinics liver Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40495-025-00429-8","article-title":"Impact of gut microbiota on drug metabolism and absorption","volume":"11","author":"Burke","year":"2025","journal-title":"Curr. Pharmacol. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","article-title":"Leaky gut: mechanisms, measurement and clinical implications in humans","volume":"68","author":"Camilleri","year":"2019","journal-title":"Gut"},{"key":"B10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","article-title":"Drug-induced liver injury: Interactions between drug properties and host factors","volume":"63","author":"Chen","year":"2015","journal-title":"J. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41401-020-00597-x","article-title":"Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis","volume":"42","author":"Chen","year":"2021","journal-title":"Acta Pharmacol Sin."},{"key":"B12","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiology-Gastrointestin Liver Physiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000450981","article-title":"Intestinal farnesoid X receptor and takeda G protein couple receptor 5 signaling in metabolic regulation","volume":"35","author":"Chiang","year":"2017","journal-title":"Digestive Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.hbpd.2023.06.008","article-title":"Contribution of gut microbiota to drug-induced liver injury","volume":"22","author":"Chu","year":"2023","journal-title":"Hepatobil Pancreatic Dis. Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s12072-021-10144-3","article-title":"Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines","volume":"15","author":"Devarbhavi","year":"2021","journal-title":"Hepatol. Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/17425255.2022.2122810","article-title":"Modeling drug-induced liver injury: current status and future prospects","volume":"18","author":"Di Zeo-S\u00e1nchez","year":"2022","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.3390\/cells11152337","article-title":"Versatile triad alliance: bile acid, taurine and microbiota","volume":"11","author":"Duszka","year":"2022","journal-title":"Cells"},{"key":"B18","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1124\/dmd.121.000415","article-title":"Pregnane X receptor and the gut-liver axis: a recent update","volume":"50","author":"Dutta","year":"2022","journal-title":"Drug Metab. Disposition"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e11621","DOI":"10.15252\/emmm.201911621","article-title":"Targeting the pregnane X receptor using microbial metabolite mimicry","volume":"12","author":"Dvo\u0159\u00e1k","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"11278","DOI":"10.7150\/thno.47289","article-title":"Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs","volume":"10","author":"Feng","year":"2020","journal-title":"Theranostics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.cgh.2022.12.040","article-title":"The evolving profile of idiosyncratic drug-induced liver injury","volume":"21","author":"Fontana","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.972518","article-title":"Antibiotics enhancing drug-induced liver injury assessed for causality using Roussel Uclaf Causality Assessment Method: Emerging role of gut microbiota dysbiosis","volume":"9","author":"Fu","year":"2022","journal-title":"Front. Med."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1432049","article-title":"Gut microbiota causally affects drug-induced liver injury via plasma metabolites: a Mendelian randomization study","volume":"15","author":"Fu","year":"2024","journal-title":"Front. Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"103316","DOI":"10.1016\/j.drudis.2022.07.001","article-title":"The role of gut microbial \u03b2-glucuronidase in drug disposition and development","volume":"27","author":"Gao","year":"2022","journal-title":"Drug Discov. Today"},{"key":"B25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.37349\/edd.2023.00034","article-title":"Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease\u2014a comprehensive narrative review","volume":"2","author":"Garc\u00eda-Cort\u00e9s","year":"2023","journal-title":"Explor. Digestive Dis."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658354","article-title":"Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation","volume":"12","author":"Gasaly","year":"2021","journal-title":"Front. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"bvz039","DOI":"10.1210\/jendso\/bvz039","article-title":"). Intestinal barrier dysfunction, LPS translocation, and disease development","volume":"4","author":"Ghosh","year":"2020","journal-title":"J. Endocrine Soc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/ph15091130","article-title":"Magnesium isoglycyrrhizinate attenuates anti-tuberculosis drug-induced liver injury by enhancing intestinal barrier function and inhibiting the LPS\/TLRs\/NF-\u03baB signaling pathway in mice","volume":"15","author":"Gong","year":"2022","journal-title":"Pharmaceuticals"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/ijms22031397","article-title":"Bile acids and microbiota: multifaceted and versatile regulators of the liver\u2013gut axis","volume":"22","author":"Gr\u00fcner","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1074\/jbc.M113.521161","article-title":"Lipopolysaccharide activates Toll-like receptor 4 (TLR4)-mediated NF-\u03baB signaling pathway and proinflammatory response in human pericytes","volume":"289","author":"Guijarro-Mu\u00f1oz","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/metabo13050629","article-title":"The engagement of cytochrome P450 enzymes in tryptophan metabolism","volume":"13","author":"Haduch","year":"2023","journal-title":"Metabolites"},{"key":"B32","doi-asserted-by":"publisher","first-page":"100620","DOI":"10.1016\/j.xinn.2024.100620","article-title":"Landscape of human organoids: Ideal model in clinics and research","volume":"5","author":"Han","year":"2024","journal-title":"Innovation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00432-024-06028-2","article-title":"The role of gut microbial \u03b2-glucuronidases in carcinogenesis and cancer treatment: a scoping review","volume":"150","author":"Hillege","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.3390\/molecules29112663","article-title":"Role of gut microecology in the pathogenesis of drug-induced liver injury and emerging therapeutic strategies","volume":"29","author":"Huang","year":"2024","journal-title":"Molecules"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1124\/dmd.115.064246","article-title":"Indole and tryptophan metabolism: endogenous and dietary routes to Ah receptor activation","volume":"43","author":"Hubbard","year":"2015","journal-title":"Drug Metab. Disposition"},{"key":"B36","doi-asserted-by":"publisher","first-page":"386186","DOI":"10.1155\/2015\/386186","article-title":"The need for biomarkers in diagnosis and prognosis of drug-induced liver disease: does metabolomics have any role","volume":"2015","author":"Iruzubieta","year":"2015","journal-title":"BioMed. Res. Int."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.55041\/IJSREM47264","article-title":"Gut microbiota in drug metabolism: A new frontier in precision medicine","author":"Kaur","year":"2025"},{"key":"B38","doi-asserted-by":"publisher","first-page":"20499361231154443","DOI":"10.1177\/20499361231154443","article-title":"Current understanding of antibiotic-associated dysbiosis and approaches for its management","volume":"10","author":"Kesavelu","year":"2023","journal-title":"Ther. Adv. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/j.gastro.2013.04.056","article-title":"Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice","volume":"145","author":"Kim","year":"2013","journal-title":"Gastroenterology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.14218\/JCTH.2022.00067S","article-title":"Epidemiology and management of drug-induced liver injury: Importance of the updated RUCAM","volume":"11","author":"Kobayashi","year":"2023","journal-title":"J. Clin. Trans. Hepatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune responses in the liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3390\/pathogens13080702","article-title":"Interplay between bile acids and intestinal microbiota: regulatory mechanisms and therapeutic potential for infections","volume":"13","author":"Li","year":"2024","journal-title":"Pathogens"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26991","article-title":"Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects for short-chain fatty acids as therapeutic targets","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1538528","article-title":"Bacteroides fragilis 839 ameliorates anti-tuberculosis drugs-induced liver injury by suppressing inflammation and regulating gut microbiota in mice","volume":"12","author":"Li","year":"2025","journal-title":"Front. Med."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.28352","article-title":"Public attitudes about the use of gene therapy in mainland China","volume":"6","author":"Li","year":"2023","journal-title":"JAMA Network Open"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/nu14081668","article-title":"Lactobacillus casei improve anti-tuberculosis drugs-induced intestinal adverse reactions in rat by modulating gut microbiota and short-chain fatty acids","volume":"14","author":"Li","year":"2022","journal-title":"Nutrients"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.3390\/ijms26094240","article-title":"Crosstalk between bile acids and intestinal epithelium: Multidimensional roles of farnesoid X receptor and Takeda G protein receptor 5","volume":"26","author":"Lin","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"792","DOI":"10.4254\/wjh.v12.i10.792","article-title":"PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease","volume":"12","author":"Lisboa","year":"2020","journal-title":"World J. Hepatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"114400","DOI":"10.1016\/j.biopha.2023.114400","article-title":"Gut microbiota affects sensitivity to immune-mediated isoniazid-induced liver injury","volume":"160","author":"Liu","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B50","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s42765-024-00395-8","article-title":"Nanofiber scaffold-based tissue engineering for the treatment of acute liver failure","volume":"6","author":"Liu","year":"2024","journal-title":"Adv Fiber Materials"},{"key":"B51","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/biom15050688","article-title":"The effect of microbiome-derived metabolites in inflammation-related cancer prevention and treatment","volume":"15","author":"Mafe","year":"2025","journal-title":"Biomolecules"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2387400","DOI":"10.1080\/19490976.2024.2387400","article-title":"Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities","volume":"16","author":"Martinelli","year":"2024","journal-title":"Gut Microbes"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.983358","article-title":"Quercetin positively affects gene expression profiles and metabolic pathway of antibiotic-treated mouse gut microbiota","volume":"13","author":"Mi","year":"2022","journal-title":"Front. Microbiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/CM9.0000000000000651","article-title":"Gut microbiota and drug-induced liver injury: An update","volume":"133","author":"Niu","year":"2020","journal-title":"Chin. Med. J."},{"key":"B55","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41575-023-00771-6","article-title":"Gut\u2013liver axis: barriers and functional circuits","volume":"20","author":"Pabst","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.tig.2023.01.002","article-title":"iPSC-derived organ-on-a-chip models for personalized human genetics and pharmacogenomics studies","volume":"39","author":"Palasantzas","year":"2023","journal-title":"Trends Genet."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2439534","DOI":"10.1080\/19490976.2024.2439534","article-title":"Dietary modulation of gut microbiota affects susceptibility to drug-induced liver injury","volume":"16","author":"Pan","year":"2024","journal-title":"Gut Microbes"},{"key":"B58","doi-asserted-by":"publisher","first-page":"101178","DOI":"10.11131\/2015\/101178","article-title":"Nuclear receptors in drug metabolism, drug response and drug interactions","volume":"2","author":"Prakash","year":"2015","journal-title":"Nucl. receptor Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"6863","DOI":"10.3390\/ijms25136863","article-title":"Idiosyncratic drug-induced liver injury and amoxicillin\u2013clavulanate: spotlight on gut microbiota, fecal metabolome and bile acid profile in patients","volume":"25","author":"Rom\u00e1n-Sag\u00fcillo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/cpt.1571","article-title":"Next-generation DILI biomarkers: prioritization of biomarkers for qualification and best practices for biospecimen collection in drug development","volume":"107","author":"Roth","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/jcp.36.3.345","article-title":"Clostridium perfringens and other anaerobes isolated from bile","volume":"36","author":"Sakaguchi","year":"1983","journal-title":"J. Clin. Pathol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/biology13110848","article-title":"Integrating molecular perspectives: Strategies for comprehensive multi-omics integrative data analysis and machine learning applications in transcriptomics, proteomics, and metabolomics","volume":"13","author":"Sanches","year":"2024","journal-title":"Biology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1016\/j.apsb.2021.11.013","article-title":"Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction","volume":"11","author":"Segovia-Zafra","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"B64","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s12072-010-9219-x","article-title":"The role of lipopolysaccharide\/toll-like receptor 4 signaling in chronic liver diseases","volume":"4","author":"Soares","year":"2010","journal-title":"Hepatol. Int."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1607899","article-title":"Bile acids affect intestinal barrier function through FXR and TGR5","volume":"12","author":"Song","year":"2025","journal-title":"Front. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.bbalip.2016.10.006","article-title":"Lipopolysaccharide biogenesis and transport at the outer membrane of Gram-negative bacteria","volume":"1862","author":"Sperandeo","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA)-Mol Cell Biol. Lipids"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1080\/10408398.2019.1598334","article-title":"Tryptophan (Trp) modulates gut homeostasis via aryl hydrocarbon receptor (AhR)","volume":"60","author":"Sun","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B68","doi-asserted-by":"crossref","DOI":"10.3389\/978-2-8325-6168-3","volume-title":"The gut-liver axis: the main role of microbiome in liver diseases","author":"Tarantino","year":"2025"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2021.605392","article-title":"Recent advances in models of immune-mediated drug-induced liver injury","volume":"3","author":"Tasnim","year":"2021","journal-title":"Front. Toxicol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: Pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"B71","doi-asserted-by":"publisher","first-page":"101976","DOI":"10.1016\/j.toxrep.2025.101976","article-title":"Insights into medication-induced liver injury: Understanding and management strategies","volume":"14","author":"Tiwari","year":"2025","journal-title":"Toxicol. Rep."},{"key":"B72","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut\u2013liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s40262-021-01032-y","article-title":"Contribution of the gut microbiome to drug disposition, pharmacokinetic and pharmacodynamic variability","volume":"60","author":"Tsunoda","year":"2021","journal-title":"Clin. Pharmacokinet."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00163","article-title":"Interactions between bacteria and bile salts in the gastrointestinal and hepatobiliary tracts","volume":"4","author":"Urdaneta","year":"2017","journal-title":"Front. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"14648","DOI":"10.1021\/acsomega.3c05846","article-title":"Short-chain fatty acid (SCFA) as a connecting link between microbiota and gut-lung axis\u2500 a potential therapeutic intervention to improve lung health","volume":"9","author":"Verma","year":"2024","journal-title":"ACS omega"},{"key":"B76","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/antiox10030390","article-title":"Oxidative stress in drug-induced liver injury (DILI): from mechanisms to biomarkers for use in clinical practice","volume":"10","author":"Villanueva-Paz","year":"2021","journal-title":"Antioxidants"},{"key":"B77","article-title":"Endogenous and xenobiotic indoles as modulators of the ahr and pxr signalling pathways","author":"Vyhl\u00eddalov\u00e1","year":"2022"},{"key":"B78","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12551-018-0491-7","article-title":"Host and microbiome multi-omics integration: applications and methodologies","volume":"11","author":"Wang","year":"2019","journal-title":"Biophys. Rev."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/microorganisms13051043","article-title":"Heterologous expression and enzymatic properties of \u03b2-glucuronidase from clostridium perfringens and its application in bilirubin transformation","volume":"13","author":"Wu","year":"2025","journal-title":"Microorganisms"},{"key":"B80","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41522-024-00577-7","article-title":"Gut and oral microbiota in gynecological cancers: interaction, mechanism, and therapeutic value","volume":"10","author":"Wu","year":"2024","journal-title":"NPJ Biofilms Microbiom"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e01596","DOI":"10.1128\/spectrum.01596-21","article-title":"Akkermansia muciniphila ameliorates acetaminophen-induced liver injury by regulating gut microbial composition and metabolism","volume":"10","author":"Xia","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.844001","article-title":"The roles of mesenchymal stem cells in gastrointestinal cancers","volume":"13","author":"Xiang","year":"2022","journal-title":"Front. Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.eng.2022.12.012","article-title":"Gut microbiota modulation: a viable strategy to address medical needs in hepatocellular carcinoma and liver transplantation","volume":"29","author":"Xiang","year":"2023","journal-title":"Engineering"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e0179586","DOI":"10.1371\/journal.pone.0179586","article-title":"Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway","volume":"12","author":"Yan","year":"2017","journal-title":"PloS One"},{"key":"B85","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.3390\/molecules27103112","article-title":"An algorithm framework for drug-induced liver injury prediction based on genetic algorithm and ensemble learning","volume":"27","author":"Yan","year":"2022","journal-title":"Molecules"},{"key":"B86","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5009\/gnl20135","article-title":"Factors related to outcomes of fecal microbiota transplantation in patients with Clostridioides difficile infection","volume":"15","author":"Yoon","year":"2020","journal-title":"Gut Liver"},{"key":"B87","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cld.2013.07.002","article-title":"Mechanisms of drug induced liver injury","volume":"17","author":"Yuan","year":"2013","journal-title":"Clinics liver Dis."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.710945","article-title":"Microbiota-host-irinotecan axis: a new insight toward irinotecan chemotherapy","volume":"11","author":"Yue","year":"2021","journal-title":"Front. Cell. infect Microbiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12865-022-00495-3","article-title":"Three important short-chain fatty acids (SCFAs) attenuate the inflammatory response induced by 5-FU and maintain the integrity of intestinal mucosal tight junction","volume":"23","author":"Yue","year":"2022","journal-title":"BMC Immunol."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1324396","article-title":"Lachnospiraceae are emerging industrial biocatalysts and biotherapeutics","volume":"11","author":"Zaplana","year":"2024","journal-title":"Front. bioeng Biotechnol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.chom.2023.04.002","article-title":"Liberation of daidzein by gut microbial \u03b2-galactosidase suppresses acetaminophen-induced hepatotoxicity in mice","volume":"31","author":"Zeng","year":"2023","journal-title":"Cell Host Microbe"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.841703","article-title":"The mechanism underlying the influence of indole-3-propionic acid: a relevance to metabolic disorders","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02033","article-title":"Aryl hydrocarbon receptor promotes IL-10 expression in inflammatory macrophages through Src-STAT3 signaling pathway","volume":"9","author":"Zhu","year":"2018","journal-title":"Front. Immunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"eaat9931","DOI":"10.1126\/science.aat9931","article-title":"Separating host and microbiome contributions to drug pharmacokinetics and toxicity","volume":"363","author":"Zimmermann","year":"2019","journal-title":"Science"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1737234\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:29:55Z","timestamp":1765780195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1737234\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":94,"alternative-id":["10.3389\/fcimb.2025.1737234"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1737234","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"article-number":"1737234"}}